BioPrax
Pre-clinical- Indications
- Implant infections, Prosthetic joint infections
Company intelligence / Profile preview
Garwood’s lead device, BioPrax™, uses a minimally invasive electrical current to disrupt bacterial biofilms on orthopedic implants. The technology aims to prevent or treat infections without removing the implant. It has received FDA Breakthrough Device designation and completed multiple rounds of preclinical testing with additional studies underway. No published pivotal clinical trial results yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Garwood Medical Devices.